Navigation Links
Analyzing Client-Centered Therapy.

Client-Centered therapy is a very old way of treating psychological disorders. Carl Rogers introduced this technique sixty years ago // .

There has been lot of questions about this technique. But it was one approach that made the psychologist to view problems of their patients from a different perspective.

It was contradictory to various existing approaches present at that time and still this therapy is not widely accepted by many psychologists.

In this therapy the therapist is not allowed to talk whereas the patient is asked to do all the talking. The therapist does not pose any questions to the patient nor does it give any advices or reassurances. It strictly not allows the doctor to agree or disagree with the client.

The therapist listens to the problems of the patient. The patient is given complete freedom to talk about his feelings.

The therapist does not provide a solution nor is allowed to give a judgment about the issue but the patients feels reassured that his problems are understood by the therapist.

This makes the patient understand better about himself and about all those aspects about himself that he has been denying. The result is that the patient understands that he has a control over all the things that is happening in his life.

On the other hand the critics criticize it because it is vague, does not provide any diagnosis and depends on the self judgement for the treatment of the patient.

The disadvantages are that they can be used to treat patients who are not willing to talk about the disease or suffer from disease which don’t allow them to perceive reality.

At present not many use it in the routine diagnosis except for a few number of supporters. Though it is not a famous technique it has been the basis of many new therapies and has influenced many therapies.


'"/>




Page: 1

Related medicine news :

1. Analyzing The Side Effects Of Some Common Medications
2. Analyzing The Risk Factors For Diabetic Neuropathy
3. Analyzing The Side Effects Of Sirolimus Stents
4. Treatment of Sickle Cell Anemia Using Gene Therapy.
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Analyzing Client Centered Therapy

(Date:7/28/2015)... ... ... The insurance telematics or usage-based insurance (UBI) industry has long called for the ... data and better understand customer behavior behind the wheel. , Up until recently, ... changing and automakers realize that with the Internet of Things, new modes of mobility ...
(Date:7/28/2015)... ... July 28, 2015 , ... Santa Rosa’s The Press Democrat announced its annual report ... Dr. Francisco Canales and Dr. Heather Furnas took the top spot as the Best ... and Dr. Canales are proud to be bestowed such a prestigious title. , ...
(Date:7/28/2015)... FL (PRWEB) , ... July 28, 2015 , ... ... and The Miriam Hospital examines outcomes for inmates who continued methadone maintenance treatment ... latter group was more likely to relapse to opiate use (1) and more ...
(Date:7/28/2015)... ... July 28, 2015 , ... Morristown Medical Center, part ... and one of the first five hospitals in the nation, to implant the newly ... on July 23, and all are in good condition. , The CoreValve® Evolut® R ...
(Date:7/28/2015)... San Francisco, California (PRWEB) , ... July 28, 2015 , ... ... released the results from a recent survey (1) examining consumers’ perspectives on ... during June 17-24, 2015, covered topics such as innovations in digital health, level of ...
Breaking Medicine News(10 mins):Health News:General Motors Engaging Insurance Partners for the Connected Car 2Health News:General Motors Engaging Insurance Partners for the Connected Car 3Health News:Dr. Canales and Dr. Furnas Honored as Sonoma County’s Best Cosmetic Surgeons 2Health News:Novus Medical Detox Center Analyzes Methadone Study Findings and Implications for Opiate Abuse Treatment 2Health News:Novus Medical Detox Center Analyzes Methadone Study Findings and Implications for Opiate Abuse Treatment 3Health News:Novus Medical Detox Center Analyzes Methadone Study Findings and Implications for Opiate Abuse Treatment 4Health News:Morristown Medical Center First Hospital in New Jersey to Implant Newly Approved Heart Valve 2Health News:Morristown Medical Center First Hospital in New Jersey to Implant Newly Approved Heart Valve 3Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 2Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 3Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 4Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 5
... has a greater impact on health than outdoor air ... their time indoors. Exposure to chemical and biological contaminants ... to the risk of developing respiratory and neurologic symptoms, ... the University of Ottawa; the Environmental Health Sciences Bureau ...
... it leads to damaged heart arteries later in life , , ... borderline high blood pressure called prehypertension are more likely later ... a new study finds. , "They,re too young to have ... J. Pletcher said of the 3,560 participants whose ages were ...
... Allows for a Single-Source Provider Solution for Ancillary Group ... ... Markets,division of Lincoln National Corporation (NYSE: LNC ) today announced it,will ... current,and future policyholders with effective dates of October 1, 2008. The,Lincoln DentalConnect(SM) ...
... report lower quality of life, poorer outlook , , MONDAY, July ... a person,s outlook on life, a new government study finds. ... lower on four scales measuring their quality of life, according ... Circulation , from researchers at the U.S. Centers for Disease ...
... The size of the financial burden on families with disabled ... to a new study conducted by the schools of social ... and Washington University in St. Louis, Mo. , According to ... burdens meaning in contrast, more vulnerable families in poorer ...
... Here are,highlights from the July issue of Mayo ... often as you wish. Mayo Clinic Women,s,HealthSource attribution ... the following subscription information as your editorial policies,permit: ... information, 800-876-8633, extension 9PK1., Vitamin D -- ...
Cached Medicine News:Health News:For Young Adults, Borderline High Blood Pressure a Threat 2Health News:Lincoln Financial Group Announces New Dental Panel of Providers 2Health News:Lincoln Financial Group Announces New Dental Panel of Providers 3Health News:Coronary Heart Disease Not a Cheery Condition 2Health News:Coronary Heart Disease Not a Cheery Condition 3Health News:UNC study: Out-of-pocket health care costs for disabled children vary widely by state 2Health News:July 2008 Mayo Clinic Women's HealthSource Highlights Vitamin D, Savvy Use of Sunscreen and Gastrointestinal Upset and Celiac Disease 2Health News:July 2008 Mayo Clinic Women's HealthSource Highlights Vitamin D, Savvy Use of Sunscreen and Gastrointestinal Upset and Celiac Disease 3Health News:July 2008 Mayo Clinic Women's HealthSource Highlights Vitamin D, Savvy Use of Sunscreen and Gastrointestinal Upset and Celiac Disease 4
(Date:7/28/2015)... , July 28, 2015 Amgen (NASDAQ: ... today declared a $0.79 per share dividend for the ... on Sept. 8, 2015, to all stockholders of record ... 2015.  About Amgen Amgen is committed ... from serious illnesses by discovering, developing, manufacturing and delivering ...
(Date:7/28/2015)... IRVINE, Calif., July 28, 2015  Edwards Lifesciences Corporation (NYSE: ... of heart valves and hemodynamic monitoring, today reported net ... million, or $1.02 per diluted share.  Adjusted net income ... per diluted share, compared to $0.88 per diluted share ... period, GAAP net income was $5.09 per diluted share, ...
(Date:7/28/2015)... LA JOLLA, Calif. , July 28, 2015 /PRNewswire/ ... a biopharmaceutical company leading the discovery and development of ... report financial results and highlights for the quarter ended ... the U.S. financial markets close. Regulus ... August 4, 2015, at 5:00 pm Eastern Daylight Time ...
Breaking Medicine Technology:Amgen Announces 2015 Third Quarter Dividend 2Amgen Announces 2015 Third Quarter Dividend 3Edwards Lifesciences Reports Second Quarter Results 2Edwards Lifesciences Reports Second Quarter Results 3Edwards Lifesciences Reports Second Quarter Results 4Edwards Lifesciences Reports Second Quarter Results 5Edwards Lifesciences Reports Second Quarter Results 6Edwards Lifesciences Reports Second Quarter Results 7Edwards Lifesciences Reports Second Quarter Results 8Edwards Lifesciences Reports Second Quarter Results 9Edwards Lifesciences Reports Second Quarter Results 10Edwards Lifesciences Reports Second Quarter Results 11Edwards Lifesciences Reports Second Quarter Results 12Edwards Lifesciences Reports Second Quarter Results 13Edwards Lifesciences Reports Second Quarter Results 14Edwards Lifesciences Reports Second Quarter Results 15Edwards Lifesciences Reports Second Quarter Results 16Edwards Lifesciences Reports Second Quarter Results 17Edwards Lifesciences Reports Second Quarter Results 18Edwards Lifesciences Reports Second Quarter Results 19Edwards Lifesciences Reports Second Quarter Results 20Edwards Lifesciences Reports Second Quarter Results 21Edwards Lifesciences Reports Second Quarter Results 22Edwards Lifesciences Reports Second Quarter Results 23Regulus Announces Timing for Second Quarter 2015 Financial Results Webcast and Conference Call 2Regulus Announces Timing for Second Quarter 2015 Financial Results Webcast and Conference Call 3
... - Inovio Biomedical,Corporation (AMEX:INO), focused on the ... diseases and a novel alternative to,surgery to ... partner, Vical Incorporated, presented positive interim,safety and ... ongoing Phase I,clinical trial using Inovio's electroporation ...
... Clinical results from a,Phase II study presented ... Society (AHS) annual meeting showed that MK-0974, ... significantly improved migraine pain relief,two hours after ... was,sustained through 24 hours. MK-0974 was generally ...
Cached Medicine Technology:Vical Interim Clinical Results Demonstrate Safety and Tolerability,of Inovio Biomedical's Electroporation DNA Delivery Technology 2Vical Interim Clinical Results Demonstrate Safety and Tolerability,of Inovio Biomedical's Electroporation DNA Delivery Technology 3Vical Interim Clinical Results Demonstrate Safety and Tolerability,of Inovio Biomedical's Electroporation DNA Delivery Technology 4Vical Interim Clinical Results Demonstrate Safety and Tolerability,of Inovio Biomedical's Electroporation DNA Delivery Technology 5Merck's Investigational Migraine Treatment MK-0974 Significantly,Improved Migraine Pain on Several Efficacy Measures in a Phase II,Study 2Merck's Investigational Migraine Treatment MK-0974 Significantly,Improved Migraine Pain on Several Efficacy Measures in a Phase II,Study 3Merck's Investigational Migraine Treatment MK-0974 Significantly,Improved Migraine Pain on Several Efficacy Measures in a Phase II,Study 4Merck's Investigational Migraine Treatment MK-0974 Significantly,Improved Migraine Pain on Several Efficacy Measures in a Phase II,Study 5
Used in conjunction with the E5381 700 Circling Band (240 style). Indications: When high buckle is required. Overall length: 11.6 mm....
Concave inner surface. Used in conjunction with the E5381 700 Circling Band (240 style). Indications: When high buckle is required. Outside diameter 33.6 mm....
Asymmetrical concave inner surface to conform to globe. Used in conjunction with the E5381 700 Circling Band (240 style). Indications: Wide scleral bed. Outside diameter 31.7 mm....
Concave inner surface to conform to globe. Used in conjunction with the E5381 700 Circling Band (240 style). Indications: wide scleral bed. Outside diameter 31.7 mm....
Medicine Products: